Safety of Psychiatric Medications during Breast-Feeding
A special issue of Women (ISSN 2673-4184).
Deadline for manuscript submissions: closed (30 August 2021) | Viewed by 392
Special Issue Editor
Interests: perinatal psychiatry; postpartum mood disorders; gender issues in schizophrenia; medication-induced hyperprolactinemia; safety of psychiatric medications in breast-feeding
Special Issue Information
Many new mothers with psychiatric illnesses discontinue their medications from fear of exposing the breast-feeding baby to the drugs. As a result, the symptoms of their psychiatric illness may emerge or worsen, exposing the infant to an unwell mother—a known risk factor contributing to adverse long term outcomes in the child. In this issue, we will review data on the safety of psychiatric medications during breast-feeding, so that women and their clinicians can make informed decisions about which medications are safe to continue on during pregnancy. Antidepressants are the most common medications that new mothers are likely to take, but we will also review data on mood stabilizers, antipschotics and anxiolytics, with the goal of providing a comprehensive overview on this topic.
Dr. Victoria Hendrick
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Women is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast-feeding
- postpartum depression
- postpartum mood disorders
- breast milk exposure
- psychiatric medications
- perinatal psychiatry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
